Form 8-K · Current report
Intuitive Surgical 8-K, filed Jul 16, 2026
- Filed
- CIK
- 0001035267
- Accession no.
- 0001035267-26-000047
Summary
Intuitive Surgical reported second-quarter 2026 revenue of $2.89 billion, up 19% from a year earlier, with GAAP net income of $818 million, or $2.29 per diluted share, and worldwide procedures up about 16%. The company placed 468 da Vinci systems and 55 Ion systems in the quarter and said it expects full-year 2026 da Vinci procedure growth of roughly 13.5% to 15.5%.
Key points
- Q2 2026 revenue was $2.89 billion, up 19% from $2.44 billion a year earlier.
- GAAP net income was $818 million, or $2.29 per diluted share; non-GAAP net income was $1.00 billion, or $2.80 per diluted share.
- Worldwide procedures grew about 16%, with da Vinci procedures up 15% and Ion procedures up 36%; Intuitive placed 468 da Vinci systems and 55 Ion systems.
- Intuitive's 2026 outlook expects da Vinci procedure growth of about 13.5% to 15.5% and non-GAAP gross margin of 68.0% to 69.0%, including an estimated 1.0% tariff impact.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On July 16, 2026, Intuitive Surgical, Inc. (“Intuitive”) issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is furnished hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of Intuitive under the Securities Act of 1933, as amended, or the Exchange Act. Item 9.01. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.